MSR161 Evolution-RMS Trials: Did Teriflunomide Perform Beyond Expectations? A Predictive Meta-Analytic Testing for Teriflunomide 14mg in Relapsing Multiple Sclerosis

Authors
Category Systematic review
JournalValue in Health
Year 2024
This article has no abstract
Epistemonikos ID: 21438f24d9ef86a6814de6994b56141511efc996
First added on: Feb 19, 2025